Seventeen patients (six women and 11 men) with Jessner's lymphocytic infiltration of the skin were studied. Nineteen biopsy specimens were analyzed with the following monoclonal antibodies: UCHL1 (T cells), 4KB5, L26 (B cells), LN1 (germinal center B cells), and BerH2 (Ki-1+ cells). Routine direct immunofluorescence was performed on 15 specimens. In 10 of 19 specimens both B and T cells were demonstrated; the B cells were in close proximity to small blood vessels. In 50% of these cases the B cell component expressed LN1 positivity. We use the term perivascular lymphocytoma to describe this pattern. Nine specimens showed T cells only. No Ki-1+ cells were detected. Routine immunofluorescence studies were performed on 15 specimens. In six of seven specimens in which there was a mixed cell population of B and T cells, results were completely negative. In contrast, six of the remaining eight specimens with a predominantly T cell population revealed weak, patchy, granular, positive labeling for immunocomponents, particularly IgM and C3 at the basement membrane. These findings suggest that Jessner's lymphocytic infiltration is a heterogeneous disorder with at least two separate immunophenotypes. The finding of perivascular follicular center differentiation in more than half the specimens suggests a possible relationship in these cases to other benign lymphoid hyperplasias (pseudolymphomas).

Download full-text PDF

Source
http://dx.doi.org/10.1016/0190-9622(90)70187-mDOI Listing

Publication Analysis

Top Keywords

jessner's lymphocytic
12
lymphocytic infiltration
12
cells
9
infiltration skin
8
perivascular lymphocytoma
8
specimens
8
ki-1+ cells
8
performed specimens
8
specimens specimens
8
specimens cells
8

Similar Publications

Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand.

Semin Arthritis Rheum

October 2024

Department of Immunology, Canterbury Health Laboratories, Christchurch, New Zealand.

Aims: We describe the varied clinical presentations, barriers in diagnosis and outcomes of anti-HMGCR myopathy in a large national cohort.

Methods: Adults found positive for serum anti-HMGCR autoantibodies via line blot or enzyme-immunoassay followed by immunoprecipitation were included in the study.

Results: Of 75 patients identified, the records of 72 (96 %) described weakness as the presenting symptom.

View Article and Find Full Text PDF
Article Synopsis
  • Lupus erythematosus tumidus (LET) is a rare skin condition that can be difficult to diagnose due to its similarities with other skin disorders.
  • A case involving a 52-year-old Hispanic female revealed that she was initially misdiagnosed with erythema nodosum and treated ineffectively before tests confirmed LET.
  • The patient responded well to treatment with hydroxychloroquine, highlighting the importance of confirmatory testing before starting treatment for skin conditions like LET.
View Article and Find Full Text PDF

Lupus erythematosus tumidus (LET) is an uncommon but distinct photosensitive subtype of cutaneous lupus erythematosus (CLE). It differs from discoid and subacute cutaneous lupus erythematosus (SCLE) clinically and pathologically. LET is marked by extreme photosensitivity and carries a much lower risk of progression to systemic disease.

View Article and Find Full Text PDF
Article Synopsis
  • Immune-mediated necrotizing myopathy (IMNM) is an inflammatory muscle disease that typically doesn't present with skin rashes, but patients with the specific HMGCR antibody may exhibit atypical skin conditions.
  • A study of 100 IIM patients revealed that 34% had skin conditions, with 42% of those with HMGCR-IMNM showing atypical lesions, which were distinct from typical IIM-related rashes.
  • Skin biopsies from HMGCR-IMNM patients revealed similar microscopic features, specifically Bcl-2-positive lymphocyte infiltrations, suggesting that these atypical skin manifestations could be a clue for diagnosing HMGCR-IMNM.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!